Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

NCT06953960

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Southern California /ID# 272414 Los Angeles, California, United States
  • Dana-Farber Cancer Institute /ID# 271846 Boston, Massachusetts, United States
  • University of Michigan Health System - Ann Arbor /ID# 271536 Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 271214 New York, United States
View all 50 locations
View Trial Details
Recruiting

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

NCT06846671

Conditions
CLL, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations
  • St Bernards Medical Center Jonesboro, Arkansas, United States
  • UCLA Department of Medicine Hematologyoncology Los Angeles, California, United States
  • Pih Health Whittier Hospital Whittier, California, United States
  • Rocky Mountain Cancer Centers (Williams) Usor Aurora, Colorado, United States
View all 130 locations
View Trial Details
Recruiting

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

NCT04973605

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Irvine Lennar Irvine, California, United States
  • University of Miami Miami, Florida, United States
View all 78 locations
View Trial Details
Recruiting

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

NCT06724237

Conditions
Anaplastic Large Cell Lymphoma, ALK-negative, Follicular Helper T-Cell Lymphoma, Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type, +12 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 165 locations
View Trial Details

Related conditions